Ascendis Pharma A/S

ASNDNASDAQHealthcare● Active

$205.94

$-4.51(-2.14%)

Market Cap$12.7B

P/E Ratio—

52W High$250.74

52W Low$160.86

Avg Volume635K

Open$210.18

Beta0.39

Net Income Financials Revenue

Ascendis Pharma A/S (ASND) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

ASND · net income · updated Jun 8, 2026

Core profitability metrics

ASND · net income · margin · TTM · CAGR

Net income was −$219.0M for FY2025 (fiscal year ending 2025-12-31), up 42.1% year-over-year. Net profit margin was -31.7%. Based on available data, Ascendis Pharma A/S has been profitable since at least 2012.

FY2025 Net Income−$219.0M▲ +42.1% YoY

Trailing 12M (TTM)$506.6Mtrailing 4 quarters sum

Net Profit Margin-31.7%−$219.0M ÷ $691.7M

YoY Change+42.1%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2012

▸ FMP /income-statement · Annual · ASND net income history · ASND profit margin

Annual net income data

ASND · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$219.0M▲ +42.1%-31.7%$691.7M

FY2024Loss−$378.1M▲ +21.5%-104.0%$363.6M

FY2023Loss−$481.4M▲ +17.4%-180.5%$266.7M

FY2022Loss−$583.2M▼ 52.0%-1139.6%$51.2M

FY2021Loss−$383.6M▲ +8.4%-4931.6%$7.8M

Net income vs peers (Healthcare)

ASND vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Ascendis Pharma A/SYOU

ASND

−$219.0M+42.1%-31.7%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Ascendis Pharma A/S (ASND) reported net income of −$219.0M for FY2025 (fiscal year ending 2025-12-31), up 42.1% year-over-year. The net profit margin was -31.7% — meaning the company kept $-0.32 of every dollar of revenue as profit.

Based on available data, Ascendis Pharma A/S has been profitable since at least 2012. Net income reached a peak of $4.1M in FY2013. Data available for 14 fiscal years.

Ascendis Pharma A/S's net profit margin was -31.7% for FY2025, based on the latest annual results.

Investors sometimes search for "Ascendis Pharma A/S net worth" — the company's market capitalization is a separate figure from ASND net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

ASND net income · 5 questions

Ascendis Pharma A/S is not currently profitable on an annual basis. The company reported a net loss of $219.0M for FY2025.

is ASND profitabledoes ASND make a profitASND profitabilityASND profitable company

▸ Source: FMP /income-statement · GAAP · Ascendis Pharma A/S · Ascendis Pharma A/S SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026